LSA
WST icon

L & S Advisors’s West Pharmaceutical WST Stock Holding History

L & S Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-525
Closed -$246K – 336
2021
Q4 		$246K Hold
525
– – 0.03% 266
2021
Q3 		$223K Buy
+525
New +$221K 0.02% 315

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

L & S Advisors's WST Position: Q1 2022 in Review

L & S Advisors sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 525 shares — an estimated $246K sold.

L & S Advisors first reported a position in WST in Q3 2021 and held it in 2 quarters. The position peaked at $246K in Q4 2021. 717 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • L & S Advisors reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • L & S Advisors sold 525 West Pharmaceutical shares in Q1 2022, an estimated $246K.
  • L & S Advisors first reported a position in West Pharmaceutical in Q3 2021 and held it in 2 quarters.
  • L & S Advisors's West Pharmaceutical position peaked at $246K in Q4 2021.
  • 717 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on L & S Advisors's 13F filing for Q1 2022, filed 11 May 2022.